Method for preventing a second heart attack employing an HMG CoA reductase inhibitor
US5622985A · kind A · utility
57Cited by
3References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 19, 1995 |
| Grant date | Apr 22, 1997 |
| Priority date | — |
| Expiry date | Apr 19, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is provided for preventing or reducing the risk of a second heart attack in a patient having a substantially normal serum cholesterol level by administering an HMG CoA reductase inhibitor such as pravastatin, alone or in combination with an ACE inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.